NCT07104110: Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- Oct 2025
- Primary completion
- Oct 2027
- Arms
- QLH12016+NHA
- Results
- None posted
- 5 Aug 2025: Trial registered